Bill Com Holdings Inc . (NYSE:BILL) reported its second-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an earnings per share (EPS) of $0.56 against a forecast of $0.46.

Haemonetics Corporation (market cap: $3.23B) reported its third-quarter earnings for fiscal year 2024, surpassing analysts' expectations with an adjusted earnings per share (EPS) of $1.19, slightly ...

Q3 2025 Earnings Conference Call February 6, 2025 8:30 AM ETCompany ParticipantsOlga Guyette - Vice President, ...